EC Number | Application | Comment | Organism |
---|---|---|---|
5.4.99.9 | drug development | UDP-galactopyranose mutase (UGM), a key enzyme in the biosynthesis of mycobacterial cell walls, is a potential target for the treatment of tuberculosis | Mycobacterium tuberculosis |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
5.4.99.9 | D322A | site-directed mutagenesis, the mutant shows altered kinetics compared to the wild-type with substrate UDP-alpha-D-galactofuranose | Mycobacterium tuberculosis |
5.4.99.9 | Y253A | site-directed mutagenesis, the mutant shows altered kinetics compared to the wild-type with substrate UDP-alpha-D-galactofuranose | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
5.4.99.9 | (4-chlorophenyl)(1-(4-chlorophenyl)-5-hydroxy-1H-pyrazol-4-yl)methanone | i.e. MS-208, a non-substrate-like inhibitor, mixed inhibition due to a lack of direct competition between MS-208 and the enzyme substrate. Molecular dynamics studies reveal that the MS-208 inhibition occurs by preventing complete closure of an active site mobile loop that is necessary for productive substrate binding. The results suggest the presence of an A-site with potential druggability. Kinetic analysis, docking, and molecular dynamics simulation and modeling of enzyme binding, overview. Model of the tertiary complex MtUGM:UDP-Galp:MS-208. Two A-loop residues, Glu321 and Asp322, are stabilized by MS-208 binding yet destabilized by UDP-Galp binding, with the former effect being more pronounced | Mycobacterium tuberculosis | |
5.4.99.9 | additional information | modeling of binding of substrate-like inhibitors using enzyme crystal structures, PDB IDs 1V0J and 4RPH. Modeling of non-substrate-like inhibitors using an integrated approach that combines saturation transfer difference (STD) NMR spectroscopy, enzyme kinetic assays, molecular modeling, and mutagenesis, leading to the discovery of a second binding site, distinct from the enzyme active site, to which (4-chlorophenyl)(1-(4-chlorophenyl)-5-hydroxy-1H-pyrazol-4-yl)methanone binds, affecting productive substrate binding at the active site and inhibiting enzyme function. Competition STD NMR experiments | Mycobacterium tuberculosis |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
5.4.99.9 | additional information | - |
additional information | Michaelis-Menten kinetics of wild-type and mutant enzymes | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.4.99.9 | UDP-alpha-D-galactopyranose | Mycobacterium tuberculosis | - |
UDP-alpha-D-galactofuranose | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.4.99.9 | Mycobacterium tuberculosis | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.4.99.9 | UDP-alpha-D-galactofuranose | UGM-catalyzed interconversion | Mycobacterium tuberculosis | UDP-alpha-D-galactopyranose | - |
r | |
5.4.99.9 | UDP-alpha-D-galactopyranose | - |
Mycobacterium tuberculosis | UDP-alpha-D-galactofuranose | - |
r | |
5.4.99.9 | UDP-alpha-D-galactopyranose | UGM-catalyzed interconversion | Mycobacterium tuberculosis | UDP-alpha-D-galactofuranose | - |
r |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
5.4.99.9 | MtUGM | - |
Mycobacterium tuberculosis |
5.4.99.9 | UGM | - |
Mycobacterium tuberculosis |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
5.4.99.9 | 37 | - |
assay at | Mycobacterium tuberculosis |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
5.4.99.9 | 7.6 | - |
assay at | Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
5.4.99.9 | FAD | FADH- | Mycobacterium tuberculosis |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
5.4.99.9 | additional information | - |
additional information | inhibition kinetic analysis | Mycobacterium tuberculosis |
EC Number | General Information | Comment | Organism |
---|---|---|---|
5.4.99.9 | physiological function | UDP-galactopyranose mutase (UGM) is a key enzyme in the biosynthesis of mycobacterial cell walls. Galactofuranose (Galf) is an essential building block of the galactan chains in the cell walls of mycobacteria | Mycobacterium tuberculosis |